U.S. Life Sciences Stock News

In early December 2025, OSE Immunotherapeutics amended its partnership with AbbVie on the pre-clinical anti-inflammatory antibody ABBV-230, taking back responsibility and funding for preclinical and Phase 1 work while AbbVie keeps exclusive rights to later-stage development and commercialization with the original royalty and milestone terms largely intact. This shift gives AbbVie continued optionality on a potential first-in-class ChemR23-targeting therapy without near-term development...

Cimpress (CMPR) has quietly turned into a strong multiyear rebound story, with the stock up roughly 30% over the past 3 months even though the 1 year return is still slightly negative. See our latest analysis for Cimpress. That recent 12.1% 1 month share price return, on top of a 29.6% 3 month share price gain and a powerful 3 year total shareholder return above 200%, suggests momentum is building again from a still recovering base. If Cimpress has you thinking about turnarounds and fresh...

Celanese (CE) just added another credential to its sustainability pitch, securing Carbon Footprint Certification for its POM ECO C grades in Germany and Texas after investing heavily in carbon capture based methanol production. See our latest analysis for Celanese. Even with this sustainability milestone, Celanese’s 30 day share price return of 11.71 percent sits against a much weaker year to date share price return of minus 36.42 percent. This mirrors a three year total shareholder return of...

Sportradar Group’s recent upgrade by S&P Global Ratings to ‘BB’ from ‘BB-’ reflects its more conservative financial policy and the completed acquisition of IMG Arena. This improved credit profile, underpinned by absorbing IMG Arena’s sports rights and data assets, could influence how investors view Sportradar’s long-term resilience. We’ll now examine how the S&P upgrade tied to IMG Arena’s acquisition reshapes Sportradar’s broader investment narrative and risk profile. Find companies with...

Plexus (PLXS) has quietly put up a strong run, with the stock up about 14% over the past month and 16% in the past 3 months, even as its 1 year return still lags. See our latest analysis for Plexus. With the share price now at $159.91 and a 30 day share price return close to 14%, Plexus is showing clear upward momentum. Its 1 year total shareholder return is still slightly negative, while multi year total shareholder returns remain strong. If Plexus has you watching for what might run next,...

In December 2025, Garmin announced that its G5000H integrated flight deck was selected by the Brazilian Air Force, via Ace Aeronautics, to modernize 24 UH-60L Black Hawk helicopter cockpits, while also unveiling the inReach Mini 3 Plus satellite communicator with voice, text and photo capabilities for off-grid adventurers. Together, these developments highlight Garmin’s ability to win complex defense avionics programs and extend its satellite communication ecosystem deeper into the outdoor...

Madrigal Pharmaceuticals recently appointed industry veteran Rita Thakkar as Senior Vice President and Chief Accounting Officer, while continuing to expand commercial access and international availability of its MASH therapy Rezdiffra, including a launch in Germany. The combination of strengthened financial leadership and widening Rezdiffra uptake, supported by broad first-line payer coverage, highlights a focus on scaling disciplined, global growth in MASH treatment. We’ll now examine how...

Wondering if PJT Partners is still a smart buy after its big run, or if the easy money has already been made? Here is a look at what the current price really implies about its value. The stock has cooled slightly in the last week, down 3.5%, but it is still up 1.8% over the last month, 8.5% year to date, and 129.8% over three years. Recent headlines have focused on a rebound in dealmaking activity and a healthier pipeline for advisory work across Wall Street. That naturally puts a specialist...

Altria Group recently announced that long-time CEO William “Billy” Gifford will retire after the company’s May 14, 2026 annual meeting, with current CFO Sal Mancuso stepping up as CEO and Heather Newman, Chief Strategy & Growth Officer, becoming CFO at the same time. This carefully sequenced leadership handover, keeping successors from inside the organization, suggests an emphasis on continuity as Altria pushes further into smoke-free and new growth categories. Next, we’ll explore how this...

Workiva Inc. recently announced that Barbara Larson will become Chief Financial Officer and Executive Vice President in January 2026, while CEO Julie Iskow steps in as interim CFO and Treasurer from late December 2025, alongside the appointment of Deepak Bharadwaj as Executive Vice President and Chief Product Officer. Together, these leadership moves bring in seasoned expertise from companies like Workday, Adobe, and ServiceNow to sharpen Workiva’s financial discipline and accelerate...

Adobe (ADBE) just wrapped up fiscal Q4 with earnings and revenue ahead of expectations, and the stock reaction says investors are already asking the next question: how durable is this AI driven momentum? See our latest analysis for Adobe. Even with the latest 7.65% one month share price return to about $356, Adobe’s year to date share price return of minus 19.18% and one year total shareholder return of minus 23.46% show improving but still fragile momentum. If Adobe’s AI push has you...

Navigator Holdings (NVGS) has quietly built an impressive track record, with shares up about 15% over the past year and more than 50% in the past 3 years, outpacing many shipping peers. See our latest analysis for Navigator Holdings. Trading at around $17.49, Navigator’s recent share price return has been modest, but the solid one year and multi year total shareholder returns suggest investors are steadily warming to its cash generation and niche gas carrier exposure. If Navigator’s steady...

Wondering if VICI Properties is quietly becoming a bargain, or if the market is correctly pricing its casino and entertainment empire today? Even though the stock is up about 3.4% over the last week, it is still roughly flat year to date at around $28.66 and only modestly positive over three years. That makes its 43.8% gain over five years look like a distant memory. Recent headlines have focused on VICI's continued role as a major landlord on the Las Vegas Strip and its steady deal making...

In the past quarter, MongoDB, Inc. reported third-quarter 2025 revenue of US$628.31 million and a net loss of US$2.01 million, issued higher revenue guidance for the fourth quarter and full year 2026, and completed a US$351.69 million buyback covering 1.77% of its shares. Together, the stronger results, upgraded outlook, and completed repurchase suggest management confidence in MongoDB’s growth trajectory and capital allocation priorities. We’ll now explore how the upgraded 2026 revenue...

In November 2025, LGI Homes closed 398 homes, including 8 current or former single-family rental properties, across 140 active selling communities. This mix of traditional and rental home closings highlights LGI Homes’ continued push to diversify revenue streams within its existing community footprint. Next, we’ll explore how softer sector demand signaled by Toll Brothers’ forecast could reshape LGI Homes’ investment narrative amid its recent November closings. We've found 13 US stocks...

If you are wondering whether GameStop is still a bargain or just a meme-era relic, you are not alone. This article unpacks what the current price really implies about its value. Despite a wild 5 year total return of roughly 450%, GameStop now trades around $21.23, with the stock down 7.7% over the last week and 30.8% year to date, while still slightly positive over 3 years. Recently, GameStop has stayed in the spotlight as traders continue to debate the companys long term business...

Delta Air Lines (DAL) has quietly outperformed many travel stocks over the past month, gaining around 15%, as investors reassess the carrier’s earnings power and valuation heading into the busy holiday travel season. See our latest analysis for Delta Air Lines. The recent 15.4% 1 month share price return has pushed Delta closer to its 69.81 dollar level highs for the year. That momentum builds on a three year total shareholder return of about 116.7%, suggesting investors are warming to its...

Wondering if Douglas Emmett is a beaten down office REIT that the market has mispriced or a value trap in plain sight? This breakdown will walk you through what the numbers actually say about its value. Despite a tough run with the share price down 1.7% over the last week, 2.6% over the last month, and almost 38% year to date, moves like this often create the kind of valuation gaps long term investors look for. Much of the recent share price pressure has come as investors rethink the future...

Eos Energy Enterprises (EOSE) jumped after traders latched onto a powerful one-two setup: a looming December 31 clean energy tax credit deadline and the company’s ongoing financial restructuring to shore up liquidity. See our latest analysis for Eos Energy Enterprises. The stock is still giving back part of a sharp multi month rally, with a recent 30 day share price return of minus 14.07 percent, but a powerful 90 day share price return of 80.98 percent and 1 year total shareholder return of...

If you have been wondering whether Chart Industries at around $205 a share is still a smart buy or already priced for perfection, you are in the right place. The stock has crept up modestly in the short term, with returns of 0.3% over the last week, 1.1% over the last month, and 8.4% year to date, building on a much bigger 76.5% gain over three years and 83.8% over five. Recent headlines have focused on Chart Industries as a key player in cryogenic equipment and clean energy infrastructure...

Wondering if TE Connectivity is still worth buying after its big run up, or if you are turning up late to the party? This piece will walk through what the current price is really baking in. Even after a small pullback of around -1.8% over the last week and -3.0% over the past month, the stock is still up an impressive 63.7% year to date and 55.7% over the last year, more than doubling over three years and five years. Recent market interest has been shaped by TE Connectivity's positioning in...

MannKind Corporation recently reported that the FDA accepted its supplemental New Drug Application for the FUROSCIX ReadyFlow Autoinjector, a rapid subcutaneous furosemide delivery device for adults with chronic heart failure or chronic kidney disease, with a PDUFA target action date of July 26, 2026. If approved, ReadyFlow could meaningfully change at-home management of fluid buildup by cutting administration time from five hours to under 10 seconds while showing bioavailability comparable...

If you are wondering whether Jackson Financial at around $105 is still good value after its huge run, or if the easier gains have already been made, this breakdown will help you size up the opportunity with a cool head. The stock has climbed 7.7% over the last week, 12.0% in the past month, and is now up 20.6% year to date and 258.8% over three years. This naturally raises questions about how much upside is left versus the risk of a pullback. Recently, investors have been paying closer...

Hamilton Insurance Group (NYSE:HG) is back in focus after fresh commentary flagged a projected 2% sales decline and a sharp earnings per share drop, highlighting weaker demand and a more fragile long term outlook. See our latest analysis for Hamilton Insurance Group. Interestingly, that softer outlook has not stopped the stock from climbing, with a 90 day share price return of 16.47% and a year to date share price return of 50.56%. This suggests momentum is still building rather than fading...